Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sub-Saharan Africa faces an epidemic of diabetes. Diabetes causes significant morbidity including visual loss from diabetic retinopathy, which is largely preventable. In this resource-poor setting, health systems are poorly organized to deliver chronic care with multiple system involvement. The specific skills and resources needed to manage diabetic retinopathy are scarce. The costs of inaction for individuals, communities and countries are likely to be high. DISCUSSION: Screening for and treatment of diabetic retinopathy have been shown to be effective, and cost-effective, in resource-rich settings. In sub-Saharan Africa, clinical services for diabetes need to be expanded with the provision of effective, integrated care, including case-finding and management of diabetic retinopathy. This should be underpinned by a high quality evidence base accounting for differences in diabetes types, resources, patients and society in Africa. Research must address the epidemiology of diabetic retinopathy in Africa, strategies for disease detection and management with laser treatment, and include health economic analyses. Models of care tailored to the local geographic and social context are most likely to be cost effective, and should draw on experience and expertise from other continents. Research into diabetic retinopathy in Africa can drive the political agenda for service development and enable informed prioritization of available health funding at a national level. Effective interventions need to be implemented in the near future to avert a large burden of visual loss from diabetic retinopathy in the continent. SUMMARY: An increase in visual loss from diabetic retinopathy is inevitable as the diabetes epidemic emerges in sub-Saharan Africa. This could be minimized by the provision of case-finding and laser treatment, but how to do this most effectively in the regional context is not known. Research into the epidemiology, case-finding and laser treatment of diabetic retinopathy in sub-Saharan Africa will highlight a poorly met need, as well as guide the development of services for that need as it expands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196 · cited 2×
“Effectiveness of laser photocoagulation for DR in the African population is assumed from landmark studies of peripheral retinal laser and macular laser in Europe and North America [13,14].”
BackgroundStratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019 · cited 3×
“The risk of development and progression of retinopathy has been shown in developed economies to be related to glycemic control or HbA1c [4-7], blood pressure [4,8-11] and blood lipid levels [12].”
BackgroundResnikoff, S., Felch, W., Gauthier, T.-M., & Spivey, B. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301378 · Cited by 405
Cited by
Ting, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
Diabetes in sub-Saharan Africa: from clinical care to health policy
Atun, R., Davies, J. I., Gale, E. A. M., Bärnighausen, T., Beran, D., Kengne, A. P., Levitt, N. S., Mangugu, F. W., Nyirenda, M. J., Ogle, G. D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30181-x · Cited by 543
Self-citationPiyasena, M. M. P. N., Murthy, G. V. S., Yip, J. L. Y., Gilbert, C., Zuurmond, M., Peto, T., Gordon, I., Hewage, S., & Kamalakannan, S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0198979 · Cited by 178
“In these 77 studies, two studies reported the outcome as a review [35,36].”
BackgroundInfluentialPiyasena, M. M. P. N., Yip, J. L. Y., MacLeod, D., Kim, M., & Gudlavalleti, V. S. M. (2019) · BMC Ophthalmology · doi:10.1186/s12886-019-1092-3 · Cited by 70
“Therefore, a comprehensive population-based DRSP may not be feasible in LMICs in the near future [8, 10].”
Background
Metadata
- Authors
- Burgess, P. I., Msukwa, G., & Beare, N. A.
- Venue
- BMC Medicine
- Published
- 2013-07-02
- Volume
- 11
- Issue
- 1
- Pages
- 157-157
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W2048017645
- Cited by
- 82
- References
- 5
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. https://app.cochat.ai/papers/10.1186/1741-7015-11-157
- The paper
- Burgess, P. I., Msukwa, G., & Beare, N. A. (2013). Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Medicine. https://doi.org/10.1186/1741-7015-11-157
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.